Citigroup’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.94K | Sell |
13,442
-66,526
| -83% | -$24.4K | ﹤0.01% | 4538 |
|
|
2025
Q1 | $20.7K | Buy |
79,968
+35,236
| +79% | +$9.13K | ﹤0.01% | 4315 |
|
|
2024
Q4 | $25.2K | Buy |
44,732
+5,040
| +13% | +$2.84K | ﹤0.01% | 4390 |
|
|
2024
Q3 | $23.8K | Buy |
39,692
+28,201
| +245% | +$16.9K | ﹤0.01% | 4371 |
|
|
2024
Q2 | $31K | Sell |
11,491
-108,017
| -90% | -$292K | ﹤0.01% | 4111 |
|
|
2024
Q1 | $613K | Buy |
+119,508
| New | +$613K | ﹤0.01% | 2726 |
|
|
2023
Q4 | – | Sell |
-18,350
| Closed | -$12.2K | – | 4895 |
|
|
2023
Q3 | $12.2K | Buy |
+18,350
| New | +$12.2K | ﹤0.01% | 3794 |
|